Antigen Information
General Information of This Antigen (ID: TAR0OVWVF)
| Antigen Name | Myeloid cell surface antigen CD33 (CD33) |
|||||
|---|---|---|---|---|---|---|
| Gene Name | CD33 |
|||||
| Gene ID | ||||||
| Synonym | SIGLEC3; Sialic acid-binding Ig-like lectin 3;gp67;CD33 |
|||||
| Sequence |
MPLLLLLPLLWAGALAMDPNFWLQVQESVTVQEGLCVLVPCTFFHPIPYYDKNSPVHGYW
FREGAIISRDSPVATNKLDQEVQEETQGRFRLLGDPSRNNCSLSIVDARRRDNGSYFFRM ERGSTKYSYKSPQLSVHVTDLTHRPKILIPGTLEPGHSKNLTCSVSWACEQGTPPIFSWL SAAPTSLGPRTTHSSVLIITPRPQDHGTNLTCQVKFAGAGVTTERTIQLNVTYVPQNPTT GIFPGDGSGKQETRAGVVHGAIGGAGVTALLALCLCLIFFIVKTHRRKAARTAVGRNDTH PTTGSASPKHQKKSKLHGPTETSSCSGAAPTVEMDEELHYASLNFHGMNPSKDTSTEYSE VRTQ Click to Show/Hide
|
|||||
| Family | Immunoglobulin family |
|||||
| Function |
Sialic-acid-binding immunoglobulin-like lectin (Siglec) that plays a role in mediating cell-cell interactions and in maintaining immune cells in a resting state. Preferentially recognizes and binds alpha-2,3- and more avidly alpha-2,6-linked sialic acid-bearing glycans. Upon engagement of ligands such as C1q or syalylated glycoproteins, two immunoreceptor tyrosine-based inhibitory motifs (ITIMs) located in CD33 cytoplasmic tail are phosphorylated by Src-like kinases such as LCK. These phosphorylations provide docking sites for the recruitment and activation of protein-tyrosine phosphatases PTPN6/SHP-1 and PTPN11/SHP- 2. In turn, these phosphatases regulate downstream pathways through dephosphorylation of signaling molecules. One of the repressive effect of CD33 on monocyte activation requires phosphoinositide 3-kinase/PI3K.
Click to Show/Hide
|
|||||
| Uniprot Entry | ||||||
| HGNC ID | ||||||
| KEGG ID | ||||||
Each Antibody-drug Conjugate and Its Component Related to This Antigen
Full List of The ADC Related to This Antigen
| The Numbers of ADCs, Their Three Components, Payload Targets, and Corresponding Diseases for This Antigens | ||||
|---|---|---|---|---|
018 (CD33)
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2024222841A1 ADC55
[1]
|
(S)B19 |
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1) |
OXDc-VA-PAB (PEG) |
019 (CD33)
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2024222841A1 ADC56
[1]
|
(S)B19 |
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1) |
OXDc-VA-PAB (PEG) |
|
|
WO2024222841A1 ADC65
[1]
|
B63 |
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1) |
Mc-Val-Ala-PABC |
020 (CD33)
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2024222841A1 ADC57
[1]
|
(S)B19 |
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1) |
OXDc-VA-PAB (PEG) |
021 (CD33)
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2024222841A1 ADC58
[1]
|
(S)B19 |
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1) |
OXDc-VA-PAB (PEG) |
022 (CD33)
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2024222841A1 ADC59
[1]
|
(S)B19 |
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1) |
OXDc-VA-PAB (PEG) |
|
|
WO2024222841A1 ADC66
[1]
|
B63 |
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1) |
Mc-Val-Ala-PABC |
15G15.3 LC K149C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CN106714844B ADC-110
[2]
|
PNU-159682 |
DNA topoisomerase 2-alpha (TOP2A) |
Undisclosed |
|
|
CN106714844B ADC-115
[2]
|
PNU-159682 |
DNA topoisomerase 2-alpha (TOP2A) |
CN106714844B-ADC-115-linker |
|
|
CN106714844B ADC-139
[2]
|
PNU-159682 |
DNA topoisomerase 2-alpha (TOP2A) |
Ethylmaleimide linker |
A recombinant anti-CD33 mAb
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
DXC007
|
Tub255 |
Microtubule (MT) |
Undisclosed |
Anti-CD3 single-chain Fv
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
DT390 anti-CD3sFv immunotoxin
[3]
|
DT390 |
Eukaryotic elongation factor 2 kinase (EEF2K) |
Undisclosed |
Anti-CD33
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
US12186310B2-34
[4]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
US12186310B2-48
[4]
|
Undisclosed |
Undisclosed |
Undisclosed |
Anti-CD33 (US12186310B2)
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
US12186310B2-8
[4]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
US12186310B2-9
[4]
|
Undisclosed |
Undisclosed |
Undisclosed |
Anti-CD33 AB1
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Anti-CD33 AB1 Compound (Ia)
[5]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
Anti-CD33 AB1 Compound (Ia) linker |
|
|
Anti-CD33 AB1 Compound (Ib)
[5]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
Anti-CD33 AB1 Compound (Ib) linker |
|
|
Anti-CD33 AB1 Compound (Ic)
[5]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
Anti-CD33 AB1 Compound (Ic) linker |
|
|
Anti-CD33 AB1 Compound (Id)
[5]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
Anti-CD33 AB1 Compound (Id) linker |
|
|
Anti-CD33 AB1 Compound (Ie)
[5]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
Anti-CD33 AB1 Compound (Ie) linker |
|
|
Anti-CD33 AB1 Compound (If)
[5]
|
NeoDegrader P6 |
Protein cereblon (CRBN) |
Anti-CD33 AB1 Compound (If) linker |
|
|
Anti-CD33 AB1 Compound (Ig)
[5]
|
NeoDegrader P2 |
Protein cereblon (CRBN) |
Anti-CD33 AB1 Compound (Ig) linker |
|
|
Anti-CD33 AB1 Compound (Ih)
[5]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
Anti-CD33 AB1 Compound (Ih) linker |
|
|
Anti-CD33 AB1 Compound (Ii)
[5]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
Anti-CD33 AB1 Compound (Ii) linker |
|
|
Anti-CD33 AB1 Compound (Ij)
[5]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
Anti-CD33 AB1 Compound (Ij) linker |
|
|
Anti-CD33 AB1 Compound (Ik)
[5]
|
NeoDegrader P14 |
Protein cereblon (CRBN) |
Anti-CD33 AB1 Compound (Ik) linker |
|
|
Anti-CD33 AB1 Compound (Il)
[5]
|
NeoDegrader P14 |
Protein cereblon (CRBN) |
Anti-CD33 AB1 Compound (Il) linker |
|
|
Anti-CD33 AB1 Compound (Im)
[5]
|
NeoDegrader P14 |
Protein cereblon (CRBN) |
Anti-CD33 AB1 Compound (Im) linker |
Anti-CD33 Anti-ody 11A1
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CD33-CPI dimer ADC
[6]
|
Bicyclopentyl-seco-CBI-dimer |
Human Deoxyribonucleic acid (hDNA) |
AcLys-Val-Cit-PABC-DMAE |
Anti-CD33 antibody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
ABBV-787
[7]
|
BET degrader |
Bromodomain and extra-terminal (BET) |
A cleavable linker |
Anti-CD33 mAb 15G15.33
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CD33 PNU ADC2-2
[8]
|
CD33 PNU ADC2-2 payload |
Undisclosed |
CD33 PNU ADC2-2 linker |
|
|
CD33 PNU ADC3-2
[8]
|
CD33 PNU ADC3-2 payload |
Undisclosed |
CD33 PNU ADC3-2 linker |
|
|
CD33 PNU ADC4-2
[8]
|
CD33 PNU ADC4-2 payload |
Undisclosed |
CD33 PNU ADC4-2 linker |
|
|
CD33-PNU-LD1
[8]
|
CD33-PNU-LD1 payload |
Undisclosed |
CD33-PNU-LD1 linker |
|
|
CD33-PNU-LD5
[8]
|
CD33-PNU-LD5 payload |
Undisclosed |
CD33-PNU-LD5 linker |
|
|
CD33-PNU-LD6
[8]
|
CD33-PNU-LD6 payload |
Undisclosed |
CD33-PNU-LD6 linker |
|
|
CD33-PNU-LD7
[8]
|
CD33-PNU-LD7 payload |
Undisclosed |
CD33-PNU-LD7 linker |
Anti-CD33 mAb humanized 2H12
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
h2H12-Compound 1
[9]
|
h2H12-compound 1 payload |
Undisclosed |
h2H12-compound 1 linker |
|
|
h2H12-Compound 2
[9]
|
h2H12-compound 2 payload |
Undisclosed |
h2H12-compound 2 linker |
|
|
h2H12-Compound 3
[9]
|
h2H12-compound 3 payload |
Undisclosed |
h2H12-compound 3 linker |
Anti-CD33 mAb murine 2H12
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
m2H12-Compound 1
[9]
|
m2H12-compound 1 payload |
Undisclosed |
m2H12-compound 1 linker |
|
|
m2H12-Compound 2
[9]
|
m2H12-compound 2 payload |
Undisclosed |
m2H12-compound 2 linker |
|
|
m2H12-Compound 3
[9]
|
m2H12-compound 3 payload |
Undisclosed |
m2H12-compound 3 linker |
anti-CD33-11A1-v1417- (K290C)- (K334C) and CD33-11A1-v1417- (K334C)- (K392C) mAb
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
H- (A114C)-#6
[10]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
H- (A114C)-#7
[10]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
H- (A114C)-#10
[10]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
H- (A114C)-#11
[10]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
H- (A114C)-#14
[10]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
H- (A114C)-#19
[10]
|
H- (A114C)-#19 Payload |
Undisclosed |
H- (A114C)-#19 Linker |
|
|
H- (A114C)-#26
[10]
|
H- (A114C)-#19 Payload |
Undisclosed |
H- (A114C)-#26 Linker |
|
|
H- (kK183C)-#26
[10]
|
H- (A114C)-#19 Payload |
Undisclosed |
H- (A114C)-#26 Linker |
|
|
H- (E380C)-#26
[10]
|
H- (A114C)-#19 Payload |
Undisclosed |
H- (A114C)-#26 Linker |
|
|
H- (A114C)-#30
[10]
|
H- (A114C)-#30 Payload |
Undisclosed |
H- (A114C)-#30 Linker |
|
|
H- (E380C)-#30
[10]
|
H- (A114C)-#30 Payload |
Undisclosed |
H- (A114C)-#30 Linker |
|
|
H- (A114C)-#35
[10]
|
H- (A114C)-#19 Payload |
Undisclosed |
H- (A114C)-#35 Linker |
|
|
CD33-11A1-v1417 (K290C)- (K334C)-#39
[10]
|
CD33-11A1-v1417 (C)-#39 Payload |
Undisclosed |
CD33-11A1-v1417 (C)-#39 Linker |
|
|
CD33-11A1-v1417 (K334C)- (K392C)-#39
[10]
|
CD33-11A1-v1417 (C)-#39 Payload |
Undisclosed |
CD33-11A1-v1417 (C)-#39 Linker |
|
|
H- (A114C)-#43
[10]
|
H- (A114C)-#30 Payload |
Undisclosed |
H- (A114C)-#43 Linker |
|
|
H- (A114C)-#46
[10]
|
H- (A114C)-#30 Payload |
Undisclosed |
H- (A114C)-#43 Linker |
|
|
H- (A114C)-#52
[10]
|
H- (A114C)-#30 Payload |
Undisclosed |
H- (A114C)-#43 Linker |
|
|
H- (A114C)-#58
[10]
|
H- (A114C)-#30 Payload |
Undisclosed |
H- (A114C)-#43 Linker |
|
|
H- (A114C)-#66
[10]
|
H- (A114C)-#30 Payload |
Undisclosed |
H- (A114C)-#66 Linker |
Anti-CD33AB
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Anti-CD33AB-Compound (Ia)
[11]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
Anti-CD33AB-Compound (Ia) linker |
|
|
Anti-CD33AB-Compound (Ib)
[11]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
Anti-CD33AB-Compound (Ib) linker |
|
|
Anti-CD33AB-Compound (Ic)
[11]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
Anti-CD33AB-Compound (Ic) linker |
|
|
Anti-CD33AB-Compound (Ie)
[11]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
Anti-CD33AB-Compound (Ie) linker |
|
|
Anti-CD33AB-Compound (Ih)
[11]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
Anti-CD33AB-Compound (Ih) linker |
CD33-11A1-v1417- kN92S-H16-D55A- K222R-hGl
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CD33-11A1-v1417- kN92S-H16-D55A- K222R-hGl-LP1
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417- kN92S-H16-D55A- K222R-hGl-LP5
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417- kN92S-H16-D55A- K222R-hGl-LP6
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417-kN92S-H16-D55A- K222R-hGl-LP7
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417- kN92S-H16-D55A- K222R-hGl-LP8
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417- kN92S-H16-D55A- K222R-hGl-LP9
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417- kN92S-H16-D55A- K222R-hGl-LP11
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417- kN92S-H16-D55A- K222R-hGl-LP12
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417- kN92S-H16-D55A- K222R-hGl-LP13
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417- kN92S-H16-D55A- K222R-hGl-LP18
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417- kN92S-H16-D55A- K222R-hGl-LP19
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417 kN92S-H16-D55A- K222R-hGl- (Q)_AcLysValCitPABC _LP21
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417 kN92S-H16-D55A- K222R-hGl- (Q)_AcLysValCitPABC_LP25
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417 kN92S-H16-D55A- K222R-hGl (Q)_AcLysValCitPABC _LP26
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417 kN92S-H16-D55A- K222R-hGl- (Q)_AcLysValCitPABC _LP27
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417 kN92S-H16-D55A- K222R-hGl- (Q)_AcLysValCitPABC _LP28
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417 kN92S-H16-D55A- K222R-hGl- (Q)_AcLysValCitPABC _LP29
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417 kN92S-H16-D55A- K222R-hGl- (Q)_AcLysValCitPABC _LP33
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417 kN92S-H16-D55A- K222R-hGl- (Q)_AcLysValCitPABC _LP34
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417 kN92S-H16-D55A- K222R-hGl- (Q)_AcLysValCitPABC _LP35
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417 kN92S-H16-D55A- K222R-hGl- (Q)_AcLysValCitPABC _LP36
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417- kN92S-H16-D55A- K222R-hGl-LP39
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417- kN92S-H16-D55A- K222R-hGl-LP40
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417- kN92S-H16-D55A- K222R-hGl-LP41
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417- kN92S-H16-D55A- K222R-hGl-LP42
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417- kN92S-H16-D55A- K222R-hGl-LP43
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417- kN92S-H16-D55A- K222R-hGl-LP44
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417- kN92S-H16-D55A- K222R-hGl-LP45
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417- kN92S-H16-D55A- K222R-hGl-LP46
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417- kN92S-H16-D55A- K222R-hGl-LP47
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
CD33-11A1-v1417-H7C-hGl
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CD33-11A1-v1417- H7C-hGl-LP19
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
CD33-11A1-v1417-hG1- (C)
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
US11365263B2 ADC#4
[13]
|
US11365263B2 ADC#6 payload |
Undisclosed |
US11365263B2 ADC#6 linker |
CD33-11A1-v1417-K334C-hG1- (C334)
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
US11365263B2 ADC#6
[13]
|
US11365263B2 ADC#6 payload |
Undisclosed |
US11365263B2 ADC#6 linker |
CD33-11A1-v1417-K334C-K392C-hG1- (C334 + C392)
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
US11365263B2 ADC#5
[13]
|
US11365263B2 ADC#6 payload |
Undisclosed |
US11365263B2 ADC#6 linker |
CD33-11A1-v1417-kK183C-hGl
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CD33-11A1-v1417- kK183C-hGl-LP2
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417- kK183C-hGl-LP48
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
CD33-11A1-v1417-LCQ05-H16-K222R-hG1
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CD33-11A1-v1417- LCQ05-H16-K222R- hG1-LP1
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417- LCQO5-H16-K222R- hGl-LP13
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417- LCQO5-H16-K222R- hGl-LP14
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD33-11A1-v1417- LCQ05-H16-K222R- hGl-LP19
[12]
|
Undisclosed |
Undisclosed |
Undisclosed |
CD33-A Anti-ody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CD33-A Antibody-Compound (X)
[14]
|
CD33-A Antibody-Compound (X) payload |
Undisclosed |
CD33-A Antibody-Compound (X) linker |
|
|
CD33-A Antibody-Compound (XI)
[14]
|
CD33-A Antibody-Compound (XI) payload |
Undisclosed |
CD33-A Antibody-Compound (XI) linker |
|
|
CD33-A Antibody-Compound (XIV)
[14]
|
CD33-A Antibody-Compound (XIV) payload |
Undisclosed |
CD33-A Antibody-Compound (XIV) linker |
|
|
CD33-A Antibody-Compound (XVIII)
[14]
|
CD33-A Antibody-Compound (XVIII) payload |
Undisclosed |
CD33-A Antibody-Compound (XVIII) linker |
|
|
CD33-A Antibody-Compound (Ie)
[14]
|
CD33-A Antibody-Compound (Ie) payload |
Undisclosed |
CD33-A Antibody-Compound (Ie) linker |
|
|
CD33-A Antibody-Compound (XIX)
[14]
|
CD33-A Antibody-Compound (XIX) payload |
Undisclosed |
CD33-A Antibody-Compound (XIX) linker |
|
|
CD33-A Antibody-Compound (Ii)
[14]
|
CD33-A Antibody-Compound (Ii) payload |
Undisclosed |
CD33-A Antibody-Compound (Ii) linker |
|
|
CD33-A Antibody-Compound (XLI)
[14]
|
CD33-A Antibody-Compound (XLI) payload |
Undisclosed |
CD33-A Antibody-Compound (XLI) linker |
|
|
CD33-A Antibody-Compound (XVI)
[14]
|
CD33-A Antibody-Compound (XIX) payload |
Undisclosed |
CD33-A Antibody-Compound (XIX) linker |
|
|
CD33-A Antibody-Compound (XL)
[14]
|
CD33-A Antibody-Compound (XL) payload |
Undisclosed |
CD33-A Antibody-Compound (XL) linker |
|
|
CD33-A Antibody-Compound (XLIII)
[14]
|
CD33-A Antibody-Compound (XLIII) payload |
Undisclosed |
CD33-A Antibody-Compound (XLIII) linker |
|
|
CD33-A Antibody-Compound (XLII)
[14]
|
CD33-A Antibody-Compound (XLII) payload |
Undisclosed |
CD33-A Antibody-Compound (XLII) linker |
|
|
CD33-A Antibody-Compound (XV)
[14]
|
CD33-A Antibody-Compound (XV) payload |
Undisclosed |
CD33-A Antibody-Compound (XV) linker |
CD33-B Anti-ody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CD33-B Antibody-Compound (X)
[14]
|
CD33-B Antibody-Compound (X) payload |
Undisclosed |
CD33-B Antibody-Compound (X) linker |
|
|
CD33-B Antibody-Compound (XI)
[14]
|
CD33-B Antibody-Compound (XI) payload |
Undisclosed |
CD33-B Antibody-Compound (XI) linker |
|
|
CD33-B Antibody-Compound (XIV)
[14]
|
CD33-B Antibody-Compound (XIV) payload |
Undisclosed |
CD33-B Antibody-Compound (XIV) linker |
|
|
CD33-B Antibody-Compound (XVIII)
[14]
|
CD33-B Antibody-Compound (XVIII) payload |
Undisclosed |
CD33-B Antibody-Compound (XVIII) linker |
|
|
CD33-B Antibody-Compound (Ie)
[14]
|
CD33-B Antibody-Compound (Ie) payload |
Undisclosed |
CD33-B Antibody-Compound (Ie) linker |
|
|
CD33-B Antibody-Compound (XIX)
[14]
|
CD33-B Antibody-Compound (XIX) payload |
Undisclosed |
CD33-B Antibody-Compound (XIX) linker |
|
|
CD33-B Antibody-Compound (Ii)
[14]
|
CD33-B Antibody-Compound (Ii) payload |
Undisclosed |
CD33-B Antibody-Compound (Ii) linker |
|
|
CD33-B Antibody-Compound (XLI)
[14]
|
CD33-B Antibody-Compound (XLI) payload |
Undisclosed |
CD33-B Antibody-Compound (XLI) linker |
|
|
CD33-B Antibody-Compound (XVI)
[14]
|
CD33-B Antibody-Compound (XIX) payload |
Undisclosed |
CD33-B Antibody-Compound (XIX) linker |
|
|
CD33-B Antibody-Compound (XL)
[14]
|
CD33-B Antibody-Compound (XL) payload |
Undisclosed |
CD33-B Antibody-Compound (XL) linker |
|
|
CD33-B Antibody-Compound (XLIII)
[14]
|
CD33-B Antibody-Compound (XLIII) payload |
Undisclosed |
CD33-B Antibody-Compound (XLIII) linker |
|
|
CD33-B Antibody-Compound (XLII)
[14]
|
CD33-B Antibody-Compound (XLII) payload |
Undisclosed |
CD33-B Antibody-Compound (XLII) linker |
|
|
CD33-B Antibody-Compound (XV)
[14]
|
CD33-B Antibody-Compound (XV) payload |
Undisclosed |
CD33-B Antibody-Compound (XV) linker |
CD33-C Anti-ody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CD33-C Antibody-Compound (X)
[14]
|
CD33-C Antibody-Compound (X) payload |
Undisclosed |
CD33-C Antibody-Compound (X) linker |
|
|
CD33-C Antibody-Compound (XI)
[14]
|
CD33-C Antibody-Compound (XI) payload |
Undisclosed |
CD33-C Antibody-Compound (XI) linker |
|
|
CD33-C Antibody-Compound (XIV)
[14]
|
CD33-C Antibody-Compound (XIV) payload |
Undisclosed |
CD33-C Antibody-Compound (XIV) linker |
|
|
CD33-C Antibody-Compound (XVIII)
[14]
|
CD33-C Antibody-Compound (XVIII) payload |
Undisclosed |
CD33-C Antibody-Compound (XVIII) linker |
|
|
CD33-C Antibody-Compound (Ie)
[14]
|
CD33-C Antibody-Compound (Ie) payload |
Undisclosed |
CD33-C Antibody-Compound (Ie) linker |
|
|
CD33-C Antibody-Compound (XIX)
[14]
|
CD33-C Antibody-Compound (XIX) payload |
Undisclosed |
CD33-C Antibody-Compound (XIX) linker |
|
|
CD33-C Antibody-Compound (Ii)
[14]
|
CD33-C Antibody-Compound (Ii) payload |
Undisclosed |
CD33-C Antibody-Compound (Ii) linker |
|
|
CD33-C Antibody-Compound (XLI)
[14]
|
CD33-C Antibody-Compound (XLI) payload |
Undisclosed |
CD33-C Antibody-Compound (XLI) linker |
|
|
CD33-C Antibody-Compound (XVI)
[14]
|
CD33-C Antibody-Compound (XIX) payload |
Undisclosed |
CD33-C Antibody-Compound (XIX) linker |
|
|
CD33-C Antibody-Compound (XL)
[14]
|
CD33-C Antibody-Compound (XL) payload |
Undisclosed |
CD33-C Antibody-Compound (XL) linker |
|
|
CD33-C Antibody-Compound (XLIII)
[14]
|
CD33-C Antibody-Compound (XLIII) payload |
Undisclosed |
CD33-C Antibody-Compound (XLIII) linker |
|
|
CD33-C Antibody-Compound (XLII)
[14]
|
CD33-C Antibody-Compound (XLII) payload |
Undisclosed |
CD33-C Antibody-Compound (XLII) linker |
|
|
CD33-C Antibody-Compound (XV)
[14]
|
CD33-C Antibody-Compound (XV) payload |
Undisclosed |
CD33-C Antibody-Compound (XV) linker |
CD33-D Anti-ody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CD33-D Antibody-Compound (X)
[14]
|
CD33-D Antibody-Compound (X) payload |
Undisclosed |
CD33-D Antibody-Compound (X) linker |
|
|
CD33-D Antibody-Compound (XI)
[14]
|
CD33-D Antibody-Compound (XI) payload |
Undisclosed |
CD33-D Antibody-Compound (XI) linker |
|
|
CD33-D Antibody-Compound (XIV)
[14]
|
CD33-D Antibody-Compound (XIV) payload |
Undisclosed |
CD33-D Antibody-Compound (XIV) linker |
|
|
CD33-D Antibody-Compound (XVIII)
[14]
|
CD33-D Antibody-Compound (XVIII) payload |
Undisclosed |
CD33-D Antibody-Compound (XVIII) linker |
|
|
CD33-D Antibody-Compound (Ie)
[14]
|
CD33-D Antibody-Compound (Ie) payload |
Undisclosed |
CD33-D Antibody-Compound (Ie) linker |
|
|
CD33-D Antibody-Compound (XIX)
[14]
|
CD33-D Antibody-Compound (XIX) payload |
Undisclosed |
CD33-D Antibody-Compound (XIX) linker |
|
|
CD33-D Antibody-Compound (Ii)
[14]
|
CD33-D Antibody-Compound (Ii) payload |
Undisclosed |
CD33-D Antibody-Compound (Ii) linker |
|
|
CD33-D Antibody-Compound (XLI)
[14]
|
CD33-D Antibody-Compound (XLI) payload |
Undisclosed |
CD33-D Antibody-Compound (XLI) linker |
|
|
CD33-D Antibody-Compound (XVI)
[14]
|
CD33-D Antibody-Compound (XIX) payload |
Undisclosed |
CD33-D Antibody-Compound (XIX) linker |
|
|
CD33-D Antibody-Compound (XL)
[14]
|
CD33-D Antibody-Compound (XL) payload |
Undisclosed |
CD33-D Antibody-Compound (XL) linker |
|
|
CD33-D Antibody-Compound (XLIII)
[14]
|
CD33-D Antibody-Compound (XLIII) payload |
Undisclosed |
CD33-D Antibody-Compound (XLIII) linker |
|
|
CD33-D Antibody-Compound (XLII)
[14]
|
CD33-D Antibody-Compound (XLII) payload |
Undisclosed |
CD33-D Antibody-Compound (XLII) linker |
|
|
CD33-D Antibody-Compound (XV)
[14]
|
CD33-D Antibody-Compound (XV) payload |
Undisclosed |
CD33-D Antibody-Compound (XV) linker |
CN105828840B_ADC-125 antibody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CN105828840B ADC-125
[15]
|
CN105828840B_ADC-125 payload |
Undisclosed |
CN105828840B_ADC-125 linker |
CN105828840B_ADC-127 antibody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CN105828840B ADC-127
[15]
|
CN105828840B_ADC-127 payload |
Undisclosed |
CN105828840B_ADC-127 linker |
CN105828840B_ADC-129 antibody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CN105828840B ADC-129
[15]
|
CN105828840B_ADC-129 payload |
Undisclosed |
CN105828840B_ADC-129 linker |
CN105828840B_ADC-131 antibody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CN105828840B ADC-131
[15]
|
CN105828840B_ADC-131 payload |
Undisclosed |
CN105828840B_ADC-131 linker |
CN105828840B_ADC-133 antibody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CN105828840B ADC-133
[15]
|
CN105828840B_ADC-133 payload |
Undisclosed |
CN105828840B_ADC-133 linker |
CN105828840B_ADC-137 antibody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CN105828840B ADC-137
[15]
|
CN105828840B_ADC-137 payload |
Undisclosed |
CN105828840B_ADC-137 linker |
CN105828840B_ADC-138 antibody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CN105828840B ADC-138
[15]
|
CN105828840B_ADC-138 payload |
Undisclosed |
CN105828840B_ADC-138 linker |
CN105828840B_ADC-139 antibody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CN105828840B ADC-139
[15]
|
CN105828840B_ADC-139 payload |
Undisclosed |
CN105828840B_ADC-139 linker |
Gemtuzumab
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Gemtuzumab ozogamicin
[16]
|
N-acetyl-gamma-calicheamicin |
Human deoxyribonucleic acid (hDNA) |
AcButDMH |
|
|
BL-M11D1
|
Ed-04 |
DNA topoisomerase 1 (TOP1) |
Gly-Mal-Gly-Gly-Phe-Gly |
|
|
Gemtuzumab-ADC-24-1
[17]
|
Gemtuzumab-ADC-24-1 payload |
Undisclosed |
Gemtuzumab-ADC-24-1 linker |
|
|
Gemtuzumab-ADC-24-2
[17]
|
Gemtuzumab-ADC-24-2 payload |
Undisclosed |
Gemtuzumab-ADC-24-2 linker |
|
|
Gemtuzumab-ADC-24-3
[17]
|
Gemtuzumab-ADC-24-3 payload |
Undisclosed |
Gemtuzumab-ADC-24-3 linker |
|
|
Gemtuzumab-ADC-24-4
[17]
|
Gemtuzumab-ADC-24-4 payload |
Undisclosed |
Gemtuzumab-ADC-24-4 linker |
|
|
Gemtuzumab-ADC-24-5
[17]
|
Gemtuzumab-ADC-24-5 payload |
Undisclosed |
Gemtuzumab-ADC-24-5 linker |
|
|
Gemtuzumab-ADC-24-6
[17]
|
Gemtuzumab-ADC-24-6 payload |
Undisclosed |
Gemtuzumab-ADC-24-6 linker |
|
|
Gemtuzumab-ADC-24-7
[17]
|
Gemtuzumab-ADC-24-7 payload |
Undisclosed |
Gemtuzumab-ADC-24-7 linker |
|
|
Gemtuzumab-ADC-24-8
[17]
|
Gemtuzumab-ADC-24-8 payload |
Undisclosed |
Gemtuzumab-ADC-24-8 linker |
|
|
Gemtuzumab-ADC-24-9
[17]
|
Gemtuzumab-ADC-24-9 payload |
Undisclosed |
Gemtuzumab-ADC-24-9 linker |
|
|
Gemtuzumab-ADC-24-10
[17]
|
Gemtuzumab-ADC-24-10 payload |
Undisclosed |
Gemtuzumab-ADC-24-10 linker |
|
|
Gemtuzumab-ADC-24-11
[17]
|
Gemtuzumab-ADC-24-11 payload |
Undisclosed |
Gemtuzumab-ADC-24-11 linker |
|
|
Gemtuzumab-ADC-24-12
[17]
|
Gemtuzumab-ADC-24-12 payload |
Undisclosed |
Gemtuzumab-ADC-24-12 linker |
|
|
Gemtuzumab-ADC-24-13
[17]
|
Gemtuzumab-ADC-24-13 payload |
Undisclosed |
Gemtuzumab-ADC-24-13 linker |
|
|
Gemtuzumab-Compound (Ia)
[11]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
Gemtuzumab-Compound (Ia) linker |
|
|
Gemtuzumab-Compound (Ib)
[11]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
Gemtuzumab-Compound (Ib) linker |
|
|
Gemtuzumab-Compound (Ic)
[11]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
Gemtuzumab-Compound (Ic) linker |
|
|
Gemtuzumab-Compound (Ie)
[11]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
Gemtuzumab-Compound (Ie) linker |
|
|
Gemtuzumab-Compound (Ih)
[11]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
Gemtuzumab-Compound (Ih) linker |
|
|
Gemtuzumab-Compound (X)
[14]
|
Gemtuzumab-Compound (X) payload |
Undisclosed |
Gemtuzumab-Compound (X) linker |
|
|
Gemtuzumab-Compound (XI)
[14]
|
Gemtuzumab-Compound (XI) payload |
Undisclosed |
Gemtuzumab-Compound (XI) linker |
|
|
Gemtuzumab-Compound (XIV)
[14]
|
Gemtuzumab-Compound (XIV) payload |
Undisclosed |
Gemtuzumab-Compound (XIV) linker |
|
|
Gemtuzumab-Compound (XVIII)
[14]
|
Gemtuzumab-Compound (XVIII) payload |
Undisclosed |
Gemtuzumab-Compound (XVIII) linker |
|
|
Gemtuzumab-Compound (Ie)
[14]
|
Gemtuzumab-Compound (Ie) payload |
Undisclosed |
Gemtuzumab-Compound (Ie) linker |
|
|
Gemtuzumab-Compound (XIX)
[14]
|
Gemtuzumab-Compound (XIX) payload |
Undisclosed |
Gemtuzumab-Compound (XIX) linker |
|
|
Gemtuzumab-Compound (Ii)
[14]
|
Gemtuzumab-Compound (Ii) payload |
Undisclosed |
Gemtuzumab-Compound (Ii) linker |
|
|
Gemtuzumab-Compound (XLI)
[14]
|
Gemtuzumab-Compound (XLI) payload |
Undisclosed |
Gemtuzumab-Compound (XLI) linker |
|
|
Gemtuzumab-Compound (XVI)
[14]
|
Gemtuzumab-Compound (XIX) payload |
Undisclosed |
Gemtuzumab-Compound (XIX) linker |
|
|
Gemtuzumab-Compound (XL)
[14]
|
Gemtuzumab-Compound (XL) payload |
Undisclosed |
Gemtuzumab-Compound (XL) linker |
|
|
Gemtuzumab-Compound (XLIII)
[14]
|
Gemtuzumab-Compound (XLIII) payload |
Undisclosed |
Gemtuzumab-Compound (XLIII) linker |
|
|
Gemtuzumab-Compound (XLII)
[14]
|
Gemtuzumab-Compound (XLII) payload |
Undisclosed |
Gemtuzumab-Compound (XLII) linker |
|
|
Gemtuzumab-Compound (XV)
[14]
|
Gemtuzumab-Compound (XV) payload |
Undisclosed |
Gemtuzumab-Compound (XV) linker |
|
|
Gemtuzumab-Compound 9
[18]
|
Mertansine DM1 |
Microtubule (MT) |
Gemtuzumab-Compound 9 linker |
|
|
Gemtuzumab-Compound 17
[18]
|
Mertansine DM4 |
Microtubule (MT) |
Gemtuzumab-Compound 17 linker |
|
|
Gemtuzumab-Compound 25
[18]
|
Monomethyl auristatin E |
Microtubule (MT) |
Gemtuzumab-Compound 25 linker |
|
|
Gemtuzumab-Compound 31
[18]
|
Auristatin 0101 |
Microtubule (MT) |
Gemtuzumab-Compound 31 linker |
|
|
Gemtuzumab-Compound 36
[18]
|
Monomethyl auristatin E |
Microtubule (MT) |
Gemtuzumab-Compound 36 linker |
|
|
Gemtuzumab-Compound 43
[18]
|
PBD dimer |
Human Deoxyribonucleic acid (hDNA) |
Gemtuzumab-Compound 43 linker |
|
|
Gemtuzumab-Compound 49
[18]
|
PBD dimer |
Human Deoxyribonucleic acid (hDNA) |
Gemtuzumab-Compound 49 linker |
|
|
Gemtuzumab-Compound 55
[18]
|
Mertansine DM1 |
Microtubule (MT) |
Gemtuzumab-Compound 55 linker |
|
|
Gemtuzumab-Compound 59
[18]
|
Mertansine DM4 |
Microtubule (MT) |
Gemtuzumab-Compound 59 linker |
|
|
Gemtuzumab-Compound 64
[18]
|
Monomethyl auristatin E |
Microtubule (MT) |
Gemtuzumab-Compound 64 linker |
|
|
Gemtuzumab-Compound 69
[18]
|
Monomethyl auristatin E |
Microtubule (MT) |
Gemtuzumab-Compound 69 linker |
|
|
Gemtuzumab-Compound 74
[18]
|
PBD dimer |
Human Deoxyribonucleic acid (hDNA) |
Gemtuzumab-Compound 74 linker |
|
|
Gemtuzumab-Compound 75
[18]
|
Monomethyl auristatin E |
Microtubule (MT) |
Gemtuzumab-Compound 75 linker |
|
|
Gemtuzumab-Compound 76
[18]
|
Monomethyl auristatin E |
Microtubule (MT) |
Gemtuzumab-Compound 76 linker |
|
|
Gemtuzumab-Compound 77
[18]
|
Mertansine DM1 |
Microtubule (MT) |
Gemtuzumab-Compound 77 linker |
|
|
Gemtuzumab-Compound 78
[18]
|
Auristatin 0101 |
Microtubule (MT) |
Gemtuzumab-Compound 78 linker |
|
|
Gemtuzumab-Compound 79
[18]
|
Auristatin 0101 |
Microtubule (MT) |
Gemtuzumab-Compound 79 linker |
|
|
Gemtuzumab-Compound 80
[18]
|
Mertansine DM4 |
Microtubule (MT) |
Gemtuzumab-Compound 80 linker |
|
|
JP7623413B2 ExampleADC46
[19]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
IGAC-89
[20]
|
IG-L-18 Payload |
Undisclosed |
IG-L-25 linker |
gemtuzumab
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
IGAC-26
[20]
|
Smol006 |
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1) |
MP-Ala-Ala-PAB |
|
|
IGAC-28
[20]
|
IG-L-1 Payload |
Undisclosed |
IG-L-1 linker |
|
|
IGAC-32
[20]
|
IG-L-1 Payload |
Undisclosed |
IG-L-1 linker |
|
|
JP7560255B2 ControlADC46
[21]
|
Undisclosed |
Undisclosed |
Undisclosed |
GM15.33 HC A118C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CN106714844B ADC-105
[2]
|
PNU-159682 |
DNA topoisomerase 2-alpha (TOP2A) |
CN106714844B-ADC-105-linker |
h2H12
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CD33-ADC
[22]
|
SG3199 |
Human Deoxyribonucleic acid (hDNA) |
Undisclosed |
|
|
TW201803600A ADC-1
[23]
|
PBD |
Undisclosed |
Mc-Val-Ala |
h2H12EC
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
TW201803600A ADC-2
[23]
|
PBD |
Undisclosed |
Undisclosed |
HuMy9-6
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
AVE9633
|
DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
huMy9-6 IgG1
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
HuMy9-6IgG1-Compound (la) DAR 8
[24]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
huMy9-6IgG1-Compound (la) DAR 8 linker |
|
|
HuMy9-6 IgG1-Compound (la) DAR 1.9
[24]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
huMy9-6 IgG1-Compound (la) DAR 1.9 linker |
|
|
HuMy9-6IgG1-Compound (la) DAR3.9
[24]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
huMy9-6IgG1-Compound (la) DAR3.9 linker |
|
|
HuMy9-6IgG1-Compound(la) DAR 5.5
[24]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
huMy9-6IgG1-Compound(la) DAR 5.5 linker |
|
|
HuMy9-6IgG1-Compound (ld) DAR 8
[24]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
huMy9-6IgG1-Compound (ld) DAR 8 linker |
huMy9-6-IgG4-S228P
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
HuMy9-6-IgG4-S228P-Compound (Ia)
[11]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
huMy9-6-IgG4-S228P-Compound (Ia) linker |
|
|
HuMy9-6-IgG4-S228P-Compound (Ib)
[11]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
huMy9-6-IgG4-S228P-Compound (Ib) linker |
|
|
HuMy9-6-IgG4-S228P-Compound (Ic)
[11]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
huMy9-6-IgG4-S228P-Compound (Ic) linker |
|
|
HuMy9-6-IgG4-S228P-Compound (Ie)
[11]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
huMy9-6-IgG4-S228P-Compound (Ie) linker |
|
|
HuMy9-6-IgG4-S228P-Compound (Ih)
[11]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
huMy9-6-IgG4-S228P-Compound (Ih) linker |
Lintuzumab
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Lintuzumab Ac-225
|
AC225 |
Undisclosed |
DOTA-P-toluene isothiocyanate |
|
|
Lintuzumab IgG1-Compound (la) DAR 8
[24]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
Lintuzumab IgG1-Compound (la) DAR 8 linker |
|
|
Lintuzumab IgG1-Compound (ld) DAR 8
[24]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
Lintuzumab IgG1-Compound (ld) DAR 8 linker |
|
|
GLK-33
[25]
|
Glucuronyl-monomethyl-auristatin E (MMAU) |
Microtubule (MT) |
Undisclosed |
OR000213
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
OR000213-Compound (Ia)
[24]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
OR000213-Compound (Ia) linker |
|
|
OR000213-Compound(la) DAR 8
[24]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
OR000213-Compound(la) DAR 8 linker |
|
|
OR000213-Compound (la) DAR 1.2
[24]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
OR000213-Compound (la) DAR 1.2 linker |
|
|
OR000213-Compound(la) DAR 1.8
[24]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
OR000213-Compound(la) DAR 1.8 linker |
|
|
OR000213-Compound(la) DAR 2.3
[24]
|
NeoDegrader P1 |
Protein cereblon (CRBN) |
OR000213-Compound(la) DAR 2.3 linker |
OR000283
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
BMS-986497
[26]
|
SMol006 |
CRBN×GSPT1 |
β-glucuronide linker |
Thio hu Anti-CD33 GM15.33 HC A118C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2014159981A2 ADC-203
[27]
|
WO2014159981A2_ADC-203 payload |
Undisclosed |
WO2014159981A2_ADC-203 linker |
|
|
WO2014159981A2 ADC-213
[27]
|
WO2014159981A2_ADC-213 payload |
Undisclosed |
WO2014159981A2_ADC-213 linker |
|
|
WO2014159981A2 ADC-222
[27]
|
WO2014159981A2_ADC-222 payload |
Undisclosed |
WO2014159981A2_ADC-222 linker |
|
|
WO2014159981A2 ADC-CD33-24
[27]
|
WO2014159981A2_ADC-CD33-24 payload |
Undisclosed |
WO2014159981A2_ADC-CD33-24 linker |
|
|
WO2014159981A2 ADC-CD33-25
[27]
|
WO2014159981A2_ADC-CD33-25 payload |
Undisclosed |
WO2014159981A2_ADC-CD33-25 linker |
|
|
WO2014159981A2 ADC-CD33-33
[27]
|
WO2014159981A2_ADC-CD33-33 payload |
Undisclosed |
WO2014159981A2_ADC-CD33-33 linker |
|
|
WO2014159981A2 ADC-CD33-37
[27]
|
WO2014159981A2_ADC-CD33-37 payload |
Undisclosed |
WO2014159981A2_ADC-CD33-37 linker |
|
|
WO2014159981A2 ADC-CD33-41
[27]
|
WO2014159981A2_ADC-CD33-41 payload |
Undisclosed |
WO2014159981A2_ADC-CD33-41 linker |
|
|
WO2014159981A2 ADC-CD33-44
[27]
|
WO2014159981A2_ADC-CD33-44 payload |
Undisclosed |
WO2014159981A2_ADC-CD33-44 linker |
Vadastuximab
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Vadastuximab talirine
|
SGD-1882 |
Human deoxyribonucleic acid (hDNA) |
Mc-Val-Ala |
|
|
JP7623413B2 ExampleADC54
[19]
|
Undisclosed |
Undisclosed |
Undisclosed |
Z4681A
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
IMGN779
|
DGN462 |
Human deoxyribonucleic acid (hDNA) |
Sulfo-SPDB |
Undisclosed
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Anti-CD33 next-generation DNA-targeting payload ADC (Pfizer)
[28]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
Indolino-benzodiazepine antibody drug conjugate
[29]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
Anti-CD3 single-chain immunotoxin
[30]
|
DT390-scFvUCHT1 |
Undisclosed |
Undisclosed |
|
|
Anti-Human CD33 BETd ADCs
[31]
|
BETd drug |
Undisclosed |
US20250000993A1 ADC Linker |
References
